Skip to main content Skip to footer


We selectively cover UK corporate and non-corporate stocks ranging from microcap up to the FTSE 250

Our output ranges from in-depth company and sector notes to innovative Quant, Strategy and cross-sector pieces

Our team of analysts are highly regarded by both institutional investors and corporate management teams as the best in the UK small and mid cap market

Key facts

13 Analysts

With an average City experience of 15 years’


Institutional Clients receive our research

13 Sectors

We cover 13 core sectors and comment on over 30 different sub sectors

Our team of research analysts provide detailed coverage on more than 140 UK small and mid cap stocks and specialist spotlight commentary on many more. We are not constrained by sectors and focus our efforts instead on providing interesting, high-value analysis on areas that will truly benefit our clients. Having a dynamic, market-led approach is what sets us apart in our landscape.

Themes that excite our experts

Alternative Assets

Cinematics & Entertainment

Clean Tech & Green Energy

Crypto Currencies

Digital Media

Drug Discoveries




Food & Beverages

Housebuilding & REITs

Life Saving Technologies


Our products

Daily Sector Emails & Spotlight Notes

Daily Research & Thematic Notes

Sector Events, Webinars & Lunches

Monthly Video Interviews & Podcasts

Latest thematic reports and sector news


Singer’s Macro Markets Update – April 2024

Jamie Constable, Market Strategist at Singer Capital Markets, is pleased to deliver his thoughts in this latest Macro Markets Update in partnership with John Hughman at Vox Markets. In this update, Jamie discusses with John topics such as inflation, signs of economic recovery in the UK, factors that may discourage the Bank of England from a rate cut as well as why defence is a sector that investors can’t afford to ignore.
Read article

Interested in receiving our research?

We have different levels of subscriptions and content access available – please contact a member of our team to find out more.

Contact us

Karl Keegan

Head of Research

Open Linkedin profile